Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$613K Buy
5,822
+87
+2% +$8.17K 0.11% 178
2025
Q3
$473K Buy
5,735
+3,731
+186% +$307K 0.09% 200
2025
Q2
$164K Sell
2,004
-464
-19% -$36.9K 0.04% 358
2025
Q1
$215K Sell
2,468
-2,298
-48% -$215K 0.05% 265
2024
Q4
$474K Sell
4,766
-2,418
-34% -$249K 0.06% 189
2024
Q3
$816K Buy
7,184
+2,988
+71% +$355K 0.13% 120
2024
Q2
$537K Buy
4,196
+4,181
+27,873% +$539K 0.07% 233
2024
Q1
$1.97K Sell
15
-4,254
-100% -$524K ﹤0.01% 399
2023
Q4
$466K Buy
4,269
+1,425
+50% +$148K 0.08% 183
2023
Q3
$293K Sell
2,844
-506
-15% -$54.5K 0.09% 231
2023
Q2
$383K Buy
+3,350
New +$380K 0.06% 265

Other funds holding MRK

ORG Partners's MRK Position: Q4 2025 in Review

ORG Partners increased its Merck (MRK) stake by 1.5% in Q4 2025, buying an estimated $8.17K and bringing the position to 5,822 shares worth $613K. The position accounts for 0.11% of the portfolio, ranked #178.

ORG Partners first reported a position in MRK in Q2 2023 and has held it in 11 quarters since. The position peaked at $816K in Q3 2024. 3,663 funds tracked by Wall St. Rank hold MRK as of Q4 2025.

  • ORG Partners held 5,822 shares of Merck worth $613K as of Q4 2025.
  • ORG Partners bought 87 Merck shares in Q4 2025, an estimated $8.17K.
  • Merck made up 0.11% of ORG Partners's portfolio in Q4 2025, its #178 holding.
  • ORG Partners first reported a position in Merck in Q2 2023 and has held it in 11 quarters since.
  • ORG Partners's Merck position peaked at $816K in Q3 2024.
  • 3,663 funds tracked by Wall St. Rank held Merck as of Q4 2025.

Based on ORG Partners's 13F filing for Q4 2025, filed 14 Jan 2026.